Anaplastic Lymphoma Kinase–Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity With Poor Prognosis - Laurent, Camille; Do, Catherine; Gascoyne, Randy D.; Lamant, Laurence; Ysebaert, Loïc; Laurent, Guy; Delsol, Georges; Brousset, Pierre (Journal of clinical oncology, 2009)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD20 - analysis; Antineoplastic Combined Chemotherapy Protocols - administration & dosage; Biological and medical sciences; Biomarkers, Tumor - analysis; Biomarkers, Tumor - genetics; Cyclophosphamide - administration & dosage; Doxorubicin - administration & dosage; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hematologic and hematopoietic diseases; Humans; Kaplan-Meier Estimate; Ki-1 Antigen - analysis; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Lymphoma, Large B-Cell, Diffuse - drug therapy; Lymphoma, Large B-Cell, Diffuse - enzymology; Lymphoma, Large B-Cell, Diffuse - genetics; Lymphoma, Large B-Cell, Diffuse - mortality; Lymphoma, Large B-Cell, Diffuse - pathology; Male; Medical sciences; Middle Aged; Neoplasm Staging; Oncogene Proteins, Fusion - analysis; Prednisone - administration & dosage; Protein-Tyrosine Kinases - analysis; Protein-Tyrosine Kinases - genetics; Receptor Protein-Tyrosine Kinases; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome; Tumors; Vincristine - administration & dosage; Young Adult; Cancerology; Histopathology; Prognosis; Lymphoproliferative syndrome; Diffuse large B cell lymphoma; B cell neoplasm; Malignant hemopathy; Anaplastic lymphoma kinase; Cancer